At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report (Second Report) stemming from its investigation into pharmacy benefit managers (PBMs) and their...more
1/23/2025
/ Antitrust Provisions ,
Competition ,
Drug Pricing ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
Health Insurance ,
Healthcare ,
Medicare ,
Medicare Part D ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Robinson-Patman Act ,
Vertical Integration